Nicola Zambrano

11PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 28, 2022
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.

Margherita Passariello, Veronica Ferrucci, Emanuele Sasso

|Mar 10, 2022
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.

Nicola Zambrano, Guendalina Froechlich, Dejan Lazarevic

|Jan 11, 2022
Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC.

Cinzia Vetrei, Margherita Passariello, Guendalina Froechlich

|Dec 24, 2021
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance.

Chiara Gentile, Arianna Finizio, Guendalina Froechlich

|Jul 02, 2021
Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments.

Cinzia Vetrei, Margherita Passariello, Guendalina Froechlich

|Jan 09, 2021
Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.

Guendalina Froechlich, Chiara Gentile, Luigia Infante

Pageof 2

Frequent Collaborators

6 joint publications

Claudia De Lorenzo

4 joint publications

Emanuele Sasso

1 joint publications

Luciana Esposito

1 joint publications

Valeria D'Argenio